The biotech company requested a trading halt before the market open on Friday. Here's why. The post Why are Mesoblast shares ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

A new study questioned the clinical utility of an algorithm meant to predict opioid use disorder (OUD) risk based on 15 ...

With its dwindling cash reserves set to run out this month, Windtree Therapeutics had looked like it was struggling to hold ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...

When Dr. Bruce Gardner saw first-hand how much harm a forcefully-pulled catheter can do to a patient, he decided to take ...

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...